Next-Generation Targeted Anti-Cancer Drug Development Platform

Biopharmaceuticals and Health

Ready for Industrial Deployment

Seek Collaboration

Tumor microenvironment-responsive nanocarrier technology for precise targeted delivery and reduced chemotherapy side effects.

Oncology specialty hospitals, pharmaceutical companies' new drug development pipelines, and clinical trial institutions

Seeking pharma partners to advance IND filing and Phase II clinical trials

Researcher Li li.research@example.edu.cn